Collection: Prodrome Sciences

FOUNDER AND CEO
Inventor. Biochemist. Neuroscientist. Synthetic organic chemist. International speaker. Entrepreneur.

Dr. Goodenowe invented an advanced mass spectrometry technology platform in 1999 that has been used to analyze thousands of human samples from around the world and continues to be the most advanced technology of its kind today. Using this technology, he established collaborations with world-renowned international researchers and physicians in dementia, Alzheimer’s, Parkinson’s, multiple sclerosis, colorectal cancer, pancreatic cancer, ovarian cancer, breast cancer, bipolar disorder, schizophrenia, and several other diseases. Dr. Goodenowe is an expert on the biochemical basis of disease. His passion is targeted optimization of human biochemistry for longevity and vitality.

Learn more at www.DrGoodenowe.com
To learn more about the science behind the Prodrome products, visit Dr. Goodenowe's Research Institute website where he shares his vast knowledge, expertise, and research.